Search Results - "Cha, Raymond"

Refine Results
  1. 1

    Next generation antibiotic combinations to combat pan-drug resistant Klebsiella pneumoniae by Kaur, Jan Naseer, Singh, Navaldeep, Smith, Nicholas M., Klem, Jack F., Cha, Raymond, Lang, Yinzhi, Chen, Liang, Kreiswirth, Barry, Holden, Patricia N., Bulitta, Jürgen B., Tsuji, Brian T.

    Published in Scientific reports (07-02-2024)
    “…Antimicrobial resistance has emerged as one of the leading public health threats of the twenty-first century. Gram-negative pathogens have been a major…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Adolescent human papillomavirus vaccination in the United States: Opportunities for integrating pharmacies into the immunization neighborhood by Fava, Joseph P., Colleran, Jacob, Bignasci, Francesca, Cha, Raymond, Kilgore, Paul E.

    Published in Human vaccines & immunotherapeutics (03-08-2017)
    “…Human Papillomavirus (HPV) vaccination faces several barriers, including a social stigma which carries religious and philosophical implications among parents…”
    Get full text
    Journal Article
  4. 4

    A Community-Based Survey to Assess Knowledge, Attitudes, Beliefs and Practices Regarding Herpes Zoster in an Urban Setting by Baalbaki, Nour A., Fava, Joseph P., Ng, Melanie, Okorafor, Ezinwanne, Nawaz, Asad, Chiu, Wesley, Salim, Abdulbaset, Cha, Raymond, Kilgore, Paul E.

    Published in Infectious diseases and therapy (01-12-2019)
    “…Introduction In the USA, nearly one in three people will experience herpes zoster (HZ) in their lifetime. Underserved communities may be at even higher risk…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Influences of Linezolid, Penicillin, and Clindamycin, Alone and in Combination, on Streptococcal Pyrogenic Exotoxin A Release by COYLE, Elizabeth A, CHA, Raymond, RYBAK, Michael J

    Published in Antimicrobial Agents and Chemotherapy (01-05-2003)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  7. 7

    Bactericidal Activities of Daptomycin, Quinupristin-Dalfopristin, and Linezolid against Vancomycin-Resistant Staphylococcus aureus in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations by CHA, Raymond, BROWN, William J, RYBAK, Michael J

    Published in Antimicrobial Agents and Chemotherapy (01-12-2003)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  8. 8

    Daptomycin Dose-Effect Relationship against Resistant Gram-Positive Organisms by CHA, Raymond, GRUCZ, Richard G, RYBAK, Michael J

    Published in Antimicrobial Agents and Chemotherapy (01-05-2003)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  9. 9

    Fluconazole for the treatment of candidiasis: 15 years experience by Cha, Raymond, Sobel, Jack D

    Published in Expert review of anti-infective therapy (01-06-2004)
    “…Candidia spp. are responsible for contributing to the increasing global prevalence of fungal infections. Fluconazole (Diflucan((R)), Pfizer) is a triazole that…”
    Get more information
    Journal Article
  10. 10

    In Vitro Activities of Quinupristin-Dalfopristin and Cefepime, Alone and in Combination with Various Antimicrobials, against Multidrug-Resistant Staphylococci and Enterococci in an In Vitro Pharmacodynamic Model by ALLEN, George P, CHA, Raymond, RYBAK, Michael J

    Published in Antimicrobial Agents and Chemotherapy (01-08-2002)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  11. 11

    Linezolid and Vancomycin, Alone and in Combination with Rifampin, Compared with Moxifloxacin against a Multidrug-Resistant and a Vancomycin-Tolerant Streptococcus pneumoniae Strain in an In Vitro Pharmacodynamic Model by CHA, Raymond, RYBAK, Michael J

    Published in Antimicrobial Agents and Chemotherapy (01-06-2003)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  12. 12

    Influence of plasma exchange on the disposition of the fourth generation cephalosporin cefepime by Ibrahim, Rami B, Liu, Chin Y, Cronin, Simon M, Murphy, Bridgette C, Cha, Raymond, Swerdlow, Paul, Avila, Tomoco, Smith, Stephen T, Lewis, Richard A, Edwards, David J

    Published in Journal of oncology pharmacy practice (01-12-2009)
    “…Cefepime, a fourth generation cephalosporin, is widely used in hematology and oncology patients. These patients may require plasma exchange (PE) for…”
    Get full text
    Journal Article
  13. 13

    Indinavir, Efavirenz, and Abacavir Pharmacokinetics in Human Immunodeficiency Virus-Infected Subjects by DiCenzo, Robert, Forrest, Alan, Squires, Kathleen E, Hammer, Scott M, Fischl, Margaret A, Wu, Hulin, Cha, Raymond, Morse, Gene D

    Published in Antimicrobial Agents and Chemotherapy (01-06-2003)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  14. 14

    In Vitro Activity of Cefepime, Imipenem, Tigecycline, and Gentamicin, Alone and in Combination, Against Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli by Cha, Raymond

    Published in Pharmacotherapy (01-03-2008)
    “…Study Objective. To evaluate the activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended‐spectrum β‐lactamase…”
    Get full text
    Journal Article
  15. 15
  16. 16

    PBP-3 directed therapy in VIM-producing Pseudomonas aeruginosa creates bacterial transformers, persisters in disguise by Smith, Nicholas M., Boissonneault, Katie Rose, Holden, Patricia N., Kaur, Jan Naseer, Klem, Jack F., Cha, Raymond, Sutton, Mark D., Tsuji, Brian T.

    “…•Aztreonam-based therapies are key for treatment of metallo-β-lactamase-producing bacteria.•VIM-2 Pseudomonas aeruginosa was studied over 7 days in the hollow…”
    Get full text
    Journal Article
  17. 17

    Combatting the Rising Tide of Antimicrobial Resistance: Pharmacokinetic/Pharmacodynamic Dosing Strategies for Maximal Precision by Chua, Hubert C., Tse, Andy, Smith, Nicholas M., Mergenhagen, Kari A., Cha, Raymond, Tsuji, Brian T.

    “…•Antibiotics pharmacokinetics/pharmacodynamics (PK/PD) play an important role in determining the optimal dosing regimen to maximize efficacy and safety.•The…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Practical considerations for vancomycin dosing in hemodialysis patients: Perspectives from the nephrology stewardship pharmacist by El Nekidy, Wasim S, Cha, Raymond, Ghazi, Islam M

    Published in Clinical nephrology (01-02-2022)
    “…Vancomycin remains the principal antibiotic used to treat methicillin-resistant in patients with chronic kidney disease stage 5 utilizing hemodialysis…”
    Get more information
    Journal Article
  20. 20

    Pharmacokinetics and investigation of optimal dose ertapenem in intermittent hemodialysis patients by Hsaiky, Lama M, Salinitri, Francine D, Wong, Judy, Jennings, Sin-Ling T, Desai, Neha H, Lobkovich, Alison M, Cha, Raymond

    Published in Nephrology, dialysis, transplantation (01-10-2019)
    “…Abstract Background Previous pharmacokinetic studies demonstrated an increase in serum ertapenem concentrations with decreasing kidney function, including…”
    Get full text
    Journal Article